These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26938683)

  • 41. Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion.
    Poh CL; Cochrane A; Galati JC; Bullock A; Celermajer DS; Gentles T; du Plessis K; Winlaw DS; Hornung T; Finucane K; d'Udekem Y
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):530-5; discussion 535. PubMed ID: 25838458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three hundred and thirty-three experiences with the bidirectional Glenn procedure in a single institute.
    Tanoue Y; Kado H; Boku N; Tatewaki H; Nakano T; Fukae K; Masuda M; Tominaga R
    Interact Cardiovasc Thorac Surg; 2007 Feb; 6(1):97-101. PubMed ID: 17669781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epicardial pacemaker implantation and follow-up in patients with a single ventricle after the Fontan operation.
    Cohen MI; Vetter VL; Wernovsky G; Bush DM; Gaynor JW; Iyer VR; Spray TL; Tanel RE; Rhodes LA
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):804-11. PubMed ID: 11279424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
    Viollet L; Thrush PT; Flanigan KM; Mendell JR; Allen HD
    Am J Cardiol; 2012 Jul; 110(1):98-102. PubMed ID: 22463839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 40-Year Follow-Up After the Fontan Operation: Long-Term Outcomes of 1,052 Patients.
    Pundi KN; Johnson JN; Dearani JA; Pundi KN; Li Z; Hinck CA; Dahl SH; Cannon BC; O'Leary PW; Driscoll DJ; Cetta F
    J Am Coll Cardiol; 2015 Oct; 66(15):1700-10. PubMed ID: 26449141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of Life and Well-Being in Adults With Fontan Physiology: Findings From the Australian and New Zealand Fontan Registry Quality of Life Study.
    Marshall KH; d'Udekem Y; Winlaw DS; Zannino D; Celermajer DS; Justo R; Iyengar A; Cordina R; Sholler GF; Woolfenden SR; Kasparian NA
    J Am Heart Assoc; 2024 Aug; 13(15):e033818. PubMed ID: 39011952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous valvulation of failing Fontan: rationale, acute effects and follow-up.
    Malekzadeh-Milani S; Ladouceur M; Iserin L; Boudjemline Y
    Arch Cardiovasc Dis; 2014 Nov; 107(11):599-606. PubMed ID: 25282330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of late post-operative cardiopulmonary responses in the Fontan versus ventricular septation for double-inlet left ventricular repair.
    Ohuchi H; Watanabe K; Kishiki K; Nii M; Wakisaka Y; Yagihara T; Echigo S
    Am J Cardiol; 2007 Jun; 99(12):1757-61. PubMed ID: 17560890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation.
    Potter BJ; Leong-Sit P; Fernandes SM; Feifer A; Mayer JE; Triedman JK; Walsh EP; Landzberg MJ; Khairy P
    Int J Cardiol; 2013 Oct; 168(4):3940-3. PubMed ID: 23870650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraatrial conduit Fontan procedure: indications, operative techniques, and clinical outcomes.
    Zhu ZQ; Hong HF; Chen HW; Zhang HB; Lu ZH; Zheng JH; Shi GC; Liu JF
    Ann Thorac Surg; 2015 Jan; 99(1):156-61. PubMed ID: 25440283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
    Raedle-Hurst TM; Koenigstein K; Gruenhage F; Raedle J; Herrmann E; Abdul-Khaliq H
    Am Heart J; 2010 Dec; 160(6):1105-12. PubMed ID: 21146665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for persistent pleural effusions after the extracardiac Fontan procedure.
    Gupta A; Daggett C; Behera S; Ferraro M; Wells W; Starnes V
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1664-9. PubMed ID: 15173721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospital costs and cost implications of co-morbid conditions for patients with single ventricle in the period through to Fontan completion.
    Huang L; Dalziel KM; Schilling C; Celermajer DS; McNeil JJ; Winlaw D; Gentles T; Radford DJ; Cheung M; Bullock A; Wheaton GR; Justo RN; Selbie LA; Forsdick V; Du Plessis K; d'Udekem Y
    Int J Cardiol; 2017 Aug; 240():178-182. PubMed ID: 28456482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of cardiac magnetic resonance imaging combined with low-dose dobutamine stress to detect an abnormal ventricular stress response in children and young adults after fontan operation at young age.
    Robbers-Visser D; Jan Ten Harkel D; Kapusta L; Strengers JL; Dalinghaus M; Meijboom FJ; Pattynama PM; Bogers AJ; Helbing WA
    Am J Cardiol; 2008 Jun; 101(11):1657-62. PubMed ID: 18489947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early reduction of the volume work of the single ventricle: the hemi-Fontan operation.
    Jacobs ML; Rychik J; Rome JJ; Apostolopoulou S; Pizarro C; Murphy JD; Norwood WI
    Ann Thorac Surg; 1996 Aug; 62(2):456-61; discussion 461-2. PubMed ID: 8694605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with prolonged recovery after the fontan operation.
    Salvin JW; Scheurer MA; Laussen PC; Mayer JE; Del Nido PJ; Pigula FA; Bacha EA; Thiagarajan RR
    Circulation; 2008 Sep; 118(14 Suppl):S171-6. PubMed ID: 18824751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renin-angiotensin-aldosterone system genotype and serum BNP in a contemporary cohort of adults late after Fontan palliation.
    Burchill LJ; Redington AN; Silversides CK; Ross HJ; Jimenez-Juan L; Mital S; Oechslin EN; Dragulescu A; Slorach C; Mertens L; Wald RM
    Int J Cardiol; 2015 Oct; 197():209-15. PubMed ID: 26142965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
    Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrioventricular valve procedures with repeat fontan operations: influence of valve pathology, ventricular function, and arrhythmias on outcome.
    Mavroudis C; Stewart RD; Backer CL; Deal BJ; Young L; Franklin WH
    Ann Thorac Surg; 2005 Jul; 80(1):29-36; discussion 36. PubMed ID: 15975335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.